Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,069.31 +50.92 (+1.01%) Dow
38,252.18 +348.89 (+0.92%) Nasdaq
15,856.27 +250.79 (+1.61%) Bitcoin USD
59,156.22 +897.59 (+1.54%) CMC Crypto 200
1,276.71 +5.97 (+0.47%)
SWTX May 2024 65.000 call
| Previous close | 0.5500 |
| Open | 0.5800 |
| Bid | 0.0000 |
| Ask | 0.7500 |
| Strike | 65.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.5500 - 0.8800 |
| Contract range | N/A |
| Volume | |
| Open interest | 110 |
GlobeNewswireSpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
– Achieved $21.0 million in OGSIVEO® (nirogacestat) net product revenue in the first quarter – – Received validation from the EMA for MAA of nirogacestat for the treatment of adults with desmoid tumors – – Initiated rolling submission of NDA to the FDA for mirdametinib for the treatment of children and adults with NF1-PN – – Phase 2b ReNeu trial results accepted for oral presentation at the 2024 ASCO Annual Meeting – STAMFORD, Conn., May 02, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc
- GlobeNewswire
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation –– Additional data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat) in adults with desmoid tumors also accepted for presentations at ASCO –STAMFORD, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that data from the Phase 2b ReNeu trial evaluating mirdame
- GlobeNewswire
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 2024 to report its first quarter financial results and discuss recent business updates. To join the live webcast and view the corresponding slides, please click here. To access the live call by phone, plea
